New drug aims to tame aggressive pancreatic cancer before surgery
Disease control
Not yet recruiting
This early-stage study is testing if adding an experimental drug called NP137 to standard chemotherapy (FOLFIRINOX) before and after surgery can help control pancreatic cancer. The goal is to see if NP137 can change the tumor's behavior to make it less aggressive and potentially …
Phase: PHASE1 • Sponsor: Aram Hezel • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC